Results 121 to 130 of about 1,775,772 (324)

Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus [PDF]

open access: yes, 1987
The murine immediate-early (IE) protein pp89 is a nonstructural virus- encoded phosphoprotein residing in the nucleus of infected cells, where it acts as transcriptional activator.
Bertholet, Christine   +4 more
core   +4 more sources

Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica

open access: yesInternational Journal of Cancer, Volume 157, Issue 12, Page 2603-2618, 15 December 2025.
What's New? Infection with human papillomavirus (HPV) is the primary cause of anal cancer, for which the majority of cases occur in women. Anal cancer screening guidelines have limited evidence to inform effective strategies for women with HIV. We designed a study that was nested within the Costa Rica HPV Vaccine Trial to understand the natural history
Cameron B. Haas   +36 more
wiley   +1 more source

Study of the protective properties of immunodominant proteins of orthopoxviruses in various methods of immunization

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии
Introduction. In 2022, the World Health Organization declared monkeypox a public health emergency. The monkeypox virus (MPV) is part of the Orthopoxvirus genus within the Poxviridae family.
Denis I. Zrelkin   +12 more
doaj   +1 more source

Clinical signs, diagnosis, and case reports of Vaccinia virus infections

open access: yesBrazilian Journal of Infectious Diseases, 2010
Vaccinia virus is responsible for a zoonosis that usually affects cattle and human beings in Brazil. The initial clinical signs of the infection are focal red skin areas, fever, and general symptoms similar to those of a cold.
Daniela Carla Medeiros-Silva   +4 more
doaj   +1 more source

Rescue of Synthetic Genomic RNA Analogs of Rabies Virus by Plasmid-Encoded Proteins [PDF]

open access: yes, 1994
Proteins eolirely expressed from cDNA wen used to rescue synthetic RNA genome analogs into infectious defective particles or rabies virus (RV). Synthetic negative-stranded RNAs coßtalning 3' · and S'-terminal RV sequences and tnlßscriptional ...
Conzelmann, Karl-Klaus, Schnell, M.-J.
core   +3 more sources

The Heat Inactivation of Vaccinia Virus [PDF]

open access: yesJournal of General Microbiology, 1958
SUMMARY: Heat inactivation curves of vaccinia virus between 50° and 60° indicate that the virus is heterogeneous in its heat sensitivity. The proportion of heat-resistant particles varies inversely with the temperature of exposure. The inactivation of heat-sensitive virus is temperature dependent and seems to be a first-order reaction, while the heat ...
openaire   +2 more sources

Humoral and functional SARS‐CoV‐2‐specific T‐cell responses elicited in chronic lymphocytic leukaemia patients with GEO‐CM04S1 a synthetic MVA‐vectored COVID‐19 vaccine

open access: yes
British Journal of Haematology, EarlyView.
Sandra Ortega‐Francisco   +24 more
wiley   +1 more source

Mutations in human dynamin block an intermediate stage in coated vesicle formation [PDF]

open access: yes, 1993
The role of human dynamin in receptor-mediated endocytosis was investigated by transient expression of GTP-binding domain mutants in mammalian cells. Using assays which detect intermediates in coated vesicle formation, the dynamin mutants were found to ...
Damke, Hanna   +5 more
core   +3 more sources

Intracellular Development of Vaccinia Virus.

open access: yesExperimental Biology and Medicine, 1952
Summary1. Electron micrographs of tissue sections of chorioallantoic membrane infected with vaccinia virus were examined. Some cells were found to be almost filled with virus, others contained the virus particles grouped in single inclusions of varying sizes.
W H, GAYLORD, J L, MELNICK, H, BUNTING
openaire   +2 more sources

Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B

open access: yesVaccines, 2019
There are few studies comparing the safety and immunogenicity of the same HIV immunogen in healthy volunteers and HIV-infected individuals. We analyzed demographics, adverse events (AEs), and immunogenicity against vaccinia virus in preventive (RISVAC02,
Elvira Couto   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy